Becton Dickinson (XSWX:BDX) Revenue: CHF17,066 Mil (TTM As of Mar. 2026)


XSWX:BDX Becton Dickinson & Co XSWX:BDX
79 GF Score
Price CHF126.68
GF Value CHF159.75
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Revenue?

Becton Dickinson XSWX:BDX 79 Revenue is CHF17,066 Mil as of Mar. 2026. GuruFocus rates XSWX:BDX with a GF Score™ of 79/100 and a GF Value™ of CHF159.75. The stock has 3 warning signs investors should review.

Becton Dickinson's revenue for the three months ended in Mar. 2026 was CHF3,711 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was CHF17,066 Mil. Becton Dickinson's Revenue per Share for the three months ended in Mar. 2026 was CHF13.23. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was CHF59.75.

Good Sign:

Becton Dickinson & Co has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Becton Dickinson was 8.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Becton Dickinson's highest 3-Year average Revenue per Share Growth Rate was 14.40% per year. The lowest was 1.40% per year. And the median was 8.20% per year.


Becton Dickinson  (XSWX:BDX) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Becton Dickinson Revenue Related Terms


Becton Dickinson Revenue Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Revenue Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,654.09 18,366.17 17,427.05 17,094.80 17,386.82

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,958.53 4,479.92 4,689.83 4,185.32 3,711.33

XSWX:BDX vs MDLN, RMD, WST: Revenue Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Revenue distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Revenue falls into.


XSWX:BDX
79GF Score
Becton Dickinson & Co XSWX:BDX
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF17,066 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of CHF17,066 Mil mean?
Becton Dickinson (XSWX:BDX) has a Revenue of CHF17,066 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Revenue too high?
Becton Dickinson's current Revenue is CHF17,066 Mil. Overall, Becton Dickinson has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Revenue compare to MDLN and RMD?
Becton Dickinson's Revenue of CHF17,066 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Revenue is CHF17,066 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Revenue of CHF17,066 Mil. The stock's GF Value™ is CHF159.75, compared to a current price of CHF126.68 — trading 20.7% below its estimated fair value. The current Revenue is CHF17,066 Mil. Becton Dickinson's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Revenue is CHF17,066 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF126.68 is trading 20.7% below its estimated GF Value™ of CHF159.75.

Key valuation signals for XSWX:BDX:

  • Revenue: CHF17,066 Mil
  • GF Value™: CHF159.75 vs. price of CHF126.68 (20.7% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
79GF Score

Get the complete analysis for XSWX:BDX

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF126.68
Price
CHF159.75
GF Value